Zepbound diarrhea and Imodium the short answer is sometimes, but only after checking with your clinician
On March 3, 2026, the drug administration fda issued over 30 warning letters to companies illegally marketing compounded versions of glp-1 medications , including investigational peptides like retatrutide
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Moreover, use of dulaglutide in people with T2DM is likely to confer additional renal benefits, and dulaglutide may be used in advanced chronic kidney disease at any eGFR level and without dose adjustment in contrast with most other noninsulin diabetes therapies (134, 135)
It neutralizes free radicals, preventing cellular damage and preserving a youthful appearance, while also supporting overall health and longevity